Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders
Levchuk LA, Ivanova SA, Semke VY · 2013 · Bull Exp Biol Med 155(1):75-77. PMID 23667876
What does this source report?
Reports endocrine changes alongside clinical improvement when Cortexin was added to standard treatment.
- Population and setting
- Patients with organic emotionally labile/asthenic disorders
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Abstract-level record does not adequately describe allocation, blinding or sample size.
- Hormone changes do not validate general stress resilience or healthy-person enhancement.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Levchuk LA, Ivanova SA, Semke VY. Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders Bull Exp Biol Med 155(1):75-77. PMID 23667876 2013.
Molekul research summary: https://molekul.io/research/bio-23667876. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry